UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Citizens National Bank Trust Department

Citizens National Bank Trust Department trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,716 shares of the healthcare conglomerate’s stock after selling 73 shares during the quarter. UnitedHealth Group makes up 1.9% of Citizens National Bank Trust Department’s holdings, making the stock its 10th biggest holding. Citizens National Bank Trust Department’s holdings in UnitedHealth Group were worth $8,962,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also bought and sold shares of UNH. Boston Financial Mangement LLC raised its position in UnitedHealth Group by 3.9% in the 4th quarter. Boston Financial Mangement LLC now owns 8,660 shares of the healthcare conglomerate’s stock valued at $4,381,000 after buying an additional 324 shares during the last quarter. First Bank & Trust boosted its holdings in shares of UnitedHealth Group by 9.5% in the fourth quarter. First Bank & Trust now owns 1,383 shares of the healthcare conglomerate’s stock worth $700,000 after acquiring an additional 120 shares during the period. Advyzon Investment Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $994,000. WealthBridge Capital Management LLC boosted its holdings in UnitedHealth Group by 1.2% in the 4th quarter. WealthBridge Capital Management LLC now owns 1,965 shares of the healthcare conglomerate’s stock valued at $994,000 after purchasing an additional 23 shares during the period. Finally, Sunpointe LLC increased its stake in UnitedHealth Group by 6.5% in the 4th quarter. Sunpointe LLC now owns 2,930 shares of the healthcare conglomerate’s stock worth $1,482,000 after acquiring an additional 179 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on UNH shares. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

UNH stock opened at $510.75 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $470.03 billion, a P/E ratio of 32.95, a P/E/G ratio of 1.37 and a beta of 0.61. The stock’s 50 day simple moving average is $520.62 and its 200 day simple moving average is $561.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.83 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.